Valnoctamide-d5 C-pPhCO2Me 6R)-6-[(2R)-2-[(2R)-2-amino-3-(methylcarbamoyl)propanamido]-2-(4-hydroxyphenyl)acetamido]-3

6R)-6-[(2R)-2-[(2R)-2-amino-3-(methylcarbamoyl)propanamido]-2-(4-hydroxyphenyl)acetamido]-3

25-Dihydroxycholecalciferol) is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs

481 nM and 358 nM for B1 receptors of guinea pig ileum membranes and CHO cells expressing human B1 receptor

Smiles: CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O

twice daily orally for 14 days) dose-dependently reduced tumor growth and also dose-dependently reduced weight of the palpable tumors at termination

Valnoctamide-d5 C-pPhCO2Me 6R)-6-[(2R)-2-[(2R)-2-amino-3-(methylcarbamoyl)propanamido]-2-(4-hydroxyphenyl)acetamido]-3Valnoctamide d5 (Valmethamide d5) is the deuterium labeled Valnoctamide. Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors. Product information CAS Number: 1190015 82 7 Molecular Weight: 148. 26 Formula: C8H17NO Chemical Name: 2 [(1,1,2,2,2 H)ethyl] 3 methylpentanamide Smiles: [2H]C([2H])([2H])C([2H])([2H])C(C(C)CC)C(N)=O